Clinical TrialsSearch results
Number of results: 1029
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- OGSG2101:Efficacy and Safety of BEACON triplet regimen for early relapse BRAF-mutated colorectal cancer
- BRAF V600E-mutated colorectal cancer
- KAGAWA Yoshinori
- 2022-01-13
Recruiting
- Phase I investigator-initiated clinical trial against differentiated thyroid cancer using TAH-1005
- Differentiated thyroid cancer (papillary cancer, follicular cancer)
- Watabe Tadashi
- 2021-12-28
Recruiting
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- Ueda Eiji
- 2021-12-24
Recruiting
- Development of ped UT-Heart
- Congenital heart disease patients with extremely complex three-dimensional structure of the heart.
- Kurosaki Kenichi
- 2021-12-22
Recruiting
- Phase II study of ramucirumab in combination with erlotinib for untreated EGFR mutation-positive non-squamous non-small cell lung cancer patients with pleural effusion: RELAY-Effusion
- EGFR mutation positive advanced non-small cell lung cancer
- Kaneda Hiroyasu
- 2021-12-20
Other
- Clinical Trial of POD T 49P
- Cataract
- Miyajima Bissen Hiroko
- 2021-12-17
Recruiting
- Survey study of smartphone app for support of gambling addiction
- gambling addiction
- Kagomoto Takao
- 2021-12-17
Recruiting
- Distal-Radial Approach using transdermal NitroGlycerin patch
- Angina pectoris
- Murai Kota
- 2021-12-01
Recruiting
- A 52-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with insulin aspart, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. (NN1535-4593:COMBINE 3)
- type 2 diabetes
- Hashida Masahiro
- 2021-11-27
Recruiting
- A Phase 3b,randomized,multicenter,open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoembolization(TACE) in intermediate-stage HepatoCellular Carcinoma
- Intermediate-stage HepatoCellular Carcinoma
- Kudo Masatoshi
- 2021-11-24